Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004579039 | SCV005066552 | pathogenic | not provided | 2023-07-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FH protein in which other variant(s) (p.Ala117Pro) have been determined to be pathogenic (PMID: 11865300, 21398687, 24334767, 31831373; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with FH-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 2-3 of the FH gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |